Phase II

Type: Keyphrase
Name: Phase II
First reported 13 hours ago - Updated 1 hour ago - 10 reports

Regeneron's would-be blockbuster completes the allergic circle with Phase II success

Regeneron Vice President of Program Direction Neil GrahamRegeneron ($REGN) and partner Sanofi ($SNY) have notched another midstage milestone with their in-development allergy drug, a victory that affirms the hypothesis behind a treatment the companies ... [Published FierceBiotech - 3 hours ago]
First reported Sep 29 2014 - Updated 6 hours ago - 2 reports

Adding cediranib to chemotherapy improves progression-free survival for metastatic or recurrent cervical cancer, phase II trial shows

For patients with cervical cancer that has recurred after treatment or has spread elsewhere in the body, adding the experimental drug cediranib to standard chemotherapy improves tumour shrinkage and adds a modest improvement in progression-free survival, ... [Published Medical News Today - 6 hours ago]
First reported 12 hours ago - Updated 6 hours ago - 2 reports

Work on phase 2 of Stamford Diversion Canal to start from November

The canal connects the upstream section of Stamford Canal to the Singapore River. It will run underneath the road, from Tanglin along Grange Road, across Hoot Kiam Road, through Irwell Bank Road, River Valley Road, off Kim Seng Road, and to the River. ... [Published Asiaone - 12 hours ago]
First reported Sep 29 2014 - Updated 12 hours ago - 3 reports

New Findings On Treatment Options -- ScienceDaily

Treating patients with high-dose radiotherapy after chemotherapy and surgery for malignant pleural mesothelioma does not achieve improvements in local relapse and overall survival, according to data from a prospective randomized phase II trial presented ... [Published DailyMe.Com - 12 hours ago]
First reported Sep 29 2014 - Updated 20 hours ago - 3 reports

Array's Melanoma Drug Promising in Phase 2

Final results from a Phase 2 trial of binimetinib in patients with advanced NRAS mutant melanoma were presented at the European Society for Medical Oncology (ESMO) Annual Meeting in Madrid, Spain.Invented by Array BioPharma Inc. and licensed to Novartis ... [Published Drug Discovery and Development - 20 hours ago]
First reported Sep 29 2014 - Updated 22 hours ago - 2 reports

Phase2 Launches Open Public For Digital Government Initiatives

September 29, 2014 · by Staff Report · in Civic Engagement, Featured, Gov 2.0, ProcurementAcquia and Phase 2 have teamed up to offer OpenPublic 1.0 – a Drupal-based content management system designed specifically for open government initiatives that is ... [Published CivSource - 22 hours ago]
Entities: Phase II, Acquia, Drupal
First reported Sep 29 2014 - Updated Sep 29 2014 - 5 reports

Arisaph Pharmaceuticals Awarded Supplemental Phase I And Phase II STTR Grants To Develop Oncology Drug Candidates

BOSTON"We believe that the continued support from the NIH for these pioneering oncology programs validates the approach we are taking to advance two distinct treatment paradigms in cancer," said Christopher P. KiritsyAbout Arisaph OncologyArisaph has ... [Published Bio-Medicine - Sep 29 2014]
First reported Sep 29 2014 - Updated Sep 29 2014 - 5 reports

Tokai Pharmaceuticals Comes To Market: Is It Worth Buying?

Summary Tokai Pharmaceuticals provides investors with a tremendous buying opportunity after its big decline since its IPO. Tokai sets itself apart from other Castration-resistant prostate cancer biotech companies by creating a unique compound. Tokai ... [Published Seeking Alpha - Sep 29 2014]
First reported Sep 29 2014 - Updated Sep 29 2014 - 8 reports

Puma Biotechnology announces positive initial results from PB272 phase II trial

6:07am EDTPuma Biotechnology Inc:Announces the positive initial data from the ongoing, open label Phase II clinical trial of its investigational drug PB272 (neratinib) for the treatment of patients with non-small cell lung cancer (NSCLC) with HER2 mutations.Says ... [Published Reuters - Sep 29 2014]
First reported Sep 28 2014 - Updated Sep 29 2014 - 3 reports

OncoMed's Demcizumab Phase 1b Clinical Trials Show Encouraging Safety and Anti-Tumor Activity at ESMO

Results Support Advancing Demcizumab Into Randomized Phase 2 Clinical TrialsMADRID and REDWOOD CITY, Calif, Sept. 28, 2014 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals, Inc. (Nasdaq:OMED), a clinical-stage company developing novel therapeutics that target ... [Published Virtual Strategy Magazine - Sep 28 2014]
First reported Sep 28 2014 - Updated Sep 28 2014 - 4 reports

Data from Ongoing Phase 2 Studies of Rucaparib in Ovarian Cancer Demonstrate Safety and Clinical Activity, Validate Differentiated Strategy

You currently are not registered for any FirstWord Pharma services.Register to FirstWord Pharma for free access to 10 articles every 30 days: Data from Ongoing Phase 2 Studies of Rucaparib in Ovarian Cancer Demonstrate Safety and Clinical Activity, Validate ... [Published FirstWord Pharma - Sep 28 2014]
First reported Sep 28 2014 - Updated Sep 28 2014 - 2 reports

Biothera to Present Late-Breaking Data from Its Phase 2

Biothera will present today results on its investigational immunotherapy Imprime PGG ® in combination with standard of care frontline chemotherapy and bevacizumab in patients with stage IV nonsquamous non-small cell…Click to Continue » ... [Published Fort Mills Times - Sep 28 2014]


"The results of this study are an important step forward for the treatment of ALL patients that are at risk to receive L-asparaginase, which remains an important unmet medical need. The virtual absence of allergic reactions, also in patients with prior allergies to L-asparaginase, is very encouraging." comments Professor Yves Betrand, hemato-oncologist at IHOP (Institute for Pediatric Hematology and Oncology) in Lyon (France) and principal investigator...
"In this day and age almost everything we use is 'smart' — smart TVs, smart phones, etc." said Nick Weiss, CEO and founder of Easy Breathe. "We're so excited that ResMed has brought the CPAP into the 21st century and made it 'smart'. The AirSense CPAPs empower our customers to get a great night's sleep and improve their overall quality of life."
The commission gave Vermont Gas "a waiver of the reporting and accounting requirements, as well as all other rules and regulations under the (federal Natural Gas Act) and (Natural Gas Policy Act) that are ordinarily applicable to natural gas companies."
...important unmet medical needs through scientific innovation," said Johan Van Hoof, global head, infectious diseases and vaccines, Janssen, adding: "This acquisition will allow us to combine their innovative compounds with our vast experience in viral diseases to deliver novel medicines and treatment options for patients worldwide."

More Content

All (7332) | News (5652) | Reports (3) | Blogs (1472) | Audio/Video (0) | Fact Sheets (27) | Press Releases (145)
sort by: Date | Relevance
MassDOT Plans to Turn an Infamous Boston Underp... [Published Bostinno - 3 mins ago]
ERYTECH Reports Positive Top-Line Phase III Res... [Published BusinessWeek - 5 mins ago]
Easy Breathe offers sleep apnea therapy device,... [Published News-Medical.Net - 8 mins ago]
U.S. crude-by-rail projects; Valero starts up P... [Published Yahoo! Maktoob News - 16 mins ago]
Big-box store coming to Parkway Shops? [Published Jacksonville Daily Record - 28 mins ago]
Vt. Gas gets federal approval for Phase II [Published Rutland Herald - 29 mins ago]
Only 5 PPP projects expected to be finished at ... [Published Philippine Daily Inquirer - 41 mins ago]
Johnson & Johnson to acquire Alios BioPharma [Published Pharma Letter - 51 mins ago]
LG visits Delhi Technological University, revie... [Published Business Standard India - 1 hour ago]
Sanofi, Regeneron's dupilumab meets goals of mi... [Published FirstWord Pharma - 1 hour ago]
Oncoceutics grabs funding in round led by Sprin... [Published PE Hub Blog - 1 hour ago]
J&J buys Alios BioPharma to gain access to infa... [Published Fortune - 1 hour ago]
J&J Goes Viral with $1.75B Alios BioPharma Acqu... [Published Genetic Engineering News - 1 hour ago]
Jim Cramer's Stop Trading: Regeneron Investors ... [Published - 1 hour ago]
Jim Cramer's Stop Trading: Regeneron Investors ... [Published The Street Latest - 2 hours ago]
Lenalidomide active in recurrent ovarian cancer [Published Orthopedics Today - 2 hours ago]
FG, EU sign N3.3 bn grant agreement to support ... [Published The Guardian Nigeria - 2 hours ago]
Minister launches Botanical Garden in E Cape [Published - 2 hours ago]
BIO Investor Forum Company Snapshot: Syntrix Bi... [Published I Am Biotech - 2 hours ago]
Lincoln sailor qualifies as Royal Navy weapons ... [Published Lincolnshire Echo - 2 hours ago]
Forum Post: Unknown source - any experience? [Published Macmillan Cancer Support - 2 hours ago]
Glen Mor: Two halves of a whole [Published - 2 hours ago]
The Lodge at Sonoma Renaissance Resort & Spa Co... [Published Stock Nod - 2 hours ago]
Updates to Oracle FLEXCUBE Help Banks Deliver a... [Published Stockboard Media Inc. - 2 hours ago]
Environmental Phase I Assessments from $ 1399 I... [Published Prlog - 2 hours ago]
J&J makes a splash in hep C with a $1.75B deal ... [Published FierceBiotech - 3 hours ago]
Regeneron's would-be blockbuster completes the ... [Published FierceBiotech - 3 hours ago]
Duke Energy announces 2014 Urban Revitalization... [Published Duke Energy - 3 hours ago]
FINRA Solicits Comment on Proposed Rule to Impl... [Published 4 Traders - 3 hours ago]
Dr. Motzer on a Phase II Trial of Nivolumab for... [Published OncLive - 3 hours ago]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
Content Volume
Document Volume


sort by: Date | Relevance
Oncoceutics grabs funding in round led by Sprin... [Published PE Hub Blog - 1 hour ago]
Oncoceutics has received an undisclosed amount of funding. Spring Mountain Capital led the round. Based in Hummelstown, Penn., Oncoceutics is a drug developer that focuses on cancer. PRESS RELEASE NEW YORK, Sept. 29, 2014 /PRNewswire/ — Spring ...
BIO Investor Forum Company Snapshot: Syntrix Bi... [Published I Am Biotech - 2 hours ago]
1. What is your company’s lead product or technology? Omnitram (O-desmethyltramadol) is a novel  oral analgesic developed by Syntrix that alleviates pain via a dual mechanism involving mu-opioid receptor activation and inhibition of the reuptake of ...
Bangladesh: 2014 Strategic Response Plan Bangla... [Published ReliefWeb - Latest Updates - 7 hours ago]
Source: UN Office for the Coordination of Humanitarian Affairs, World Food Programme, UN Children's Fund, Food and Agriculture Organization, WASH Cluster, Nutrition Cluster, Food Security ClusterCountry: Bangladesh SUMMARY Strategic objectives ...
Uganda: Uganda Food Security Outlook Update Sep... [Published ReliefWeb - Latest Updates - 9 hours ago]
Source: Famine Early Warning System NetworkCountry: Uganda The below-average harvest will temporarily relieve the Crisis (IPC Phase 3) in Karamoja KEY MESSAGES Delayed and below-average green and dry sorghum harvests in Karamoja will increase food ...
Regeneron and Sanofi Announce Positive Phase 2 ... [Published PR Newswire: Health - 13 hours ago]
TARRYTOWN, N.Y. and PARIS, Sept. 30, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi (EURONEXT: SAN and NYSE: SNY) today announced that a Phase 2a proof-of-concept study of dupilumab, an investigational therapy that blocks ...
1 2 3 4 5 6 7 8 9 10 ...

Press Releases

sort by: Date | Relevance
Merrimack Pharmaceuticals Presents Additional P... [Published GlobeNewswire: Advertising News - 5 hours ago]
Sanofi and Regeneron Announce Positive Phase 2 ... [Published - Last press releases - 13 hours ago]
Aerojet Rocketdyne Supports United Launch Allia... [Published GlobeNewswire: Acquisitions News - 23 hours ago]
Acasti Reports Successful CaPre(R) Phase II TRI... [Published GlobeNewswire: Acquisitions News - Sep 29 2014]
Bionomics Presents BNC105 Phase II Renal Cancer... [Published GlobeNewswire: Acquisitions News - Sep 29 2014]
1 2 3 4 5 6 7 8 9 10 ...
Contact Us

Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.